Norway· NO-ID_396EB619-8123-41EC-8635-9E103A1378A8

Omnipaque

A iohexol product containing iohexol, registered in Norway by GE Healthcare AS. The same ATC class is registered in 17 of our 19 countries.

ATC V08AB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedOmnipaqueATCV08AB02REGISTER NO.NO-ID_396EB619-8123-4…PACKS LISTED11CHECKEDSeptember 25, 2026

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose

Iohexol · ATC V08AB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Iohexol
Manufacturer
GE Healthcare AS
Country
Norway (NO)
ATC code
V08AB02
ATC class
Iohexol
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 11

5 priced
  • no_merkevare_id
    ID_396EB619-8123-41EC-8635-9E103A1378A8
  • no_varenummer
    582650
    10 x 100
    NOK 5694.3
  • no_varenummer
    582692
    10 x 200
    NOK 10306.9
  • no_varenummer
    019112
    10 x 50
    NOK 2966.3
  • no_varenummer
    077059
    4 x 700
    NOK 13794.3
  • no_varenummer
    582809
    6 x 500
    NOK 14777
  • gtin
    7046265826507
  • gtin
    7046265826927
  • gtin
    7046260191129
  • gtin
    27037960645924
  • gtin
    7046265828099

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Iohexol · interactions on record

353 records

  • 286 severe
  • 54 moderate
  • 13 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Accupaque, Iovision
  • Belgium · Omnipaque
  • Bulgaria · Kopaq, Контамедиа Йох
  • Cyprus · Omnipaque
  • Czechia · Omnipaque
  • Germany · Accupaque, Iovision
  • Estonia · Iohexol Imax, Omnipaque
  • Spain · Omnipaque
  • Finland · Omnipaque
  • France · Omnipaque
  • United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
  • Greece · Omnipaque
  • Croatia · Omnipaque
  • Hungary · Iohexol Wogen, Omnipaque
  • Ireland · Omnipaque
  • Iceland · Omnipaque
  • Italy · Omnipaque
  • Lithuania · Iohexol Icg Farma, Iohexol Imax
  • Luxembourg · Omnipaque
  • Latvia · Iohexol Imax, Omnipaque
  • Malta · Omnipaque
  • Netherlands · Iohexol Adoh, Omnipaque
  • Poland · Omnipaque
  • Portugal · Iohexol Imax, Omnipaque
  • Romania · Omnipaque
  • Sweden · Iovision, Omnipaque
  • Slovenia · Omnipaque
  • Slovakia · Omnipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b276c381-daef-4d8d-9a14-5181c87ce0a6
GET /v1/drugs/b276c381-daef-4d8d-9a14-5181c87ce0a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Joheksol",
  "merkevare_id": "ID_396EB619-8123-41EC-8635-9E103A1378A8",
  "name_form_strength": "Omnipaque inj, oppl 350 mg I/ml",
  "prescription_group": "C"
}

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.